Skip to main content

Market Overview

Recap: AngioDynamics Q3 Earnings


Shares of AngioDynamics (NASDAQ:ANGO) jumped over 7% after the company reported upbeat Q3 results.

Quarterly Results

Earnings per share fell 94.74% year over year to $0.01, which beat the estimate of ($0.03).

Revenue of $69,780,000 lower by 19.18% from the same period last year, which beat the estimate of $68,550,000.

Looking Ahead

AngioDynamics hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Apr 07, 2020

Time: 10:03 PM ET

Webcast URL:

Price Action

Company's 52-week high was at $23.61

Company's 52-week low was at $7.48

Price action over last quarter: down 28.94%

Company Description

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.


Related Articles (ANGO)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at